|
Name |
16-O-deacetylhelvolic acid 21,16-lactone
|
Molecular Formula | C31H40O6 | |
IUPAC Name* |
[(1S,2S,4S,9R,12S,13R,17S,18S,19S)-1,2,13,17-tetramethyl-7-(4-methylpent-3-enyl)-6,16,20-trioxo-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-7,14-dien-19-yl] acetate
|
|
SMILES |
C[C@H]1[C@@H]2[C@@H](C(=O)[C@]3([C@H]([C@]2(C=CC1=O)C)CC[C@@H]4[C@@]3(C[C@H]5C4=C(C(=O)O5)CCC=C(C)C)C)C)OC(=O)C
|
|
InChI |
InChI=1S/C31H40O6/c1-16(2)9-8-10-19-24-20-11-12-23-29(5)14-13-21(33)17(3)25(29)26(36-18(4)32)27(34)31(23,7)30(20,6)15-22(24)37-28(19)35/h9,13-14,17,20,22-23,25-26H,8,10-12,15H2,1-7H3/t17-,20+,22+,23+,25-,26+,29-,30+,31-/m1/s1
|
|
InChIKey |
UJLGIFPRBONJKE-PREXDRGQSA-N
|
|
Synonyms |
CHEMBL4211894; 16-O-deacetylhelvolic acid 21,16-lactone
|
|
CAS | NA | |
PubChem CID | 139590094 | |
ChEMBL ID | CHEMBL4211894 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 508.6 | ALogp: | 5.3 |
HBD: | 0 | HBA: | 6 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 86.7 | Aromatic Rings: | 5 |
Heavy Atoms: | 37 | QED Weighted: | 0.365 |
Caco-2 Permeability: | -4.993 | MDCK Permeability: | 0.00002830 |
Pgp-inhibitor: | 0.962 | Pgp-substrate: | 0.638 |
Human Intestinal Absorption (HIA): | 0.028 | 20% Bioavailability (F20%): | 0.019 |
30% Bioavailability (F30%): | 0.059 |
Blood-Brain-Barrier Penetration (BBB): | 0.963 | Plasma Protein Binding (PPB): | 98.75% |
Volume Distribution (VD): | 2.119 | Fu: | 4.22% |
CYP1A2-inhibitor: | 0.038 | CYP1A2-substrate: | 0.201 |
CYP2C19-inhibitor: | 0.041 | CYP2C19-substrate: | 0.615 |
CYP2C9-inhibitor: | 0.159 | CYP2C9-substrate: | 0.185 |
CYP2D6-inhibitor: | 0.058 | CYP2D6-substrate: | 0.09 |
CYP3A4-inhibitor: | 0.737 | CYP3A4-substrate: | 0.58 |
Clearance (CL): | 10.312 | Half-life (T1/2): | 0.069 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.753 |
Drug-inuced Liver Injury (DILI): | 0.569 | AMES Toxicity: | 0.031 |
Rat Oral Acute Toxicity: | 0.983 | Maximum Recommended Daily Dose: | 0.916 |
Skin Sensitization: | 0.277 | Carcinogencity: | 0.853 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.018 |
Respiratory Toxicity: | 0.984 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003847 | 0.897 | D0X7XG | 0.327 | ||||
ENC005152 | 0.652 | D09WYX | 0.279 | ||||
ENC001480 | 0.633 | D0D2TN | 0.263 | ||||
ENC003484 | 0.618 | D0G7KJ | 0.261 | ||||
ENC005487 | 0.618 | D0E9KA | 0.255 | ||||
ENC003780 | 0.608 | D03ZZK | 0.252 | ||||
ENC005151 | 0.557 | D0W2EK | 0.244 | ||||
ENC005155 | 0.543 | D0H2MO | 0.242 | ||||
ENC005236 | 0.540 | D09IEE | 0.241 | ||||
ENC005154 | 0.540 | D01ZOG | 0.239 |